Delivery Order SPE2DB24D2205-SPE2DB25FEFNL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,793.41 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.53 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veterans' healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $54,001.92 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency awarded a delivery order valued at $45,565.02 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order, which is not set-aside, is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal healthcare systems to prevent blood clots...
- The Defense Logistics Agency awarded a delivery order valued at $44,263.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a brand-name anticoagulant medication commonly used in...
- The Defense Logistics Agency awarded a delivery order valued at $10,329.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used for stroke prevention and blood clot treatment, representing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $9,066.65. This firm fixed-price delivery order, with an ultimate completion date of June 12, 2025, represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely prescribed anticoagulant medication used in military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,011.76 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used primarily for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order valued at $6,889.44 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count package), with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare systems for...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFNLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $23,619.60 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is a brand-name anticoagulant medication used in military and veteran healthcare systems to prevent blood clots and reduce stroke risk in patients with atrial fibrillation and other conditions. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders for diverse pharmaceutical products demonstrates its established capability to meet federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 7/29/25 |